Scarica l'app Stockscreener
9.30
5.58%
-0.55
Dopo l'orario di chiusura:
9.20
-0.10
-1.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot - Yahoo Finance
Transcript : Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10 - marketscreener.com
Novavax at Citi summit: partnerships extend cash runway By Investing.com - Investing.com India
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference - Yahoo Finance
Novavax at cantor healthcare conference: pivot to licensing gains steam By Investing.com - Investing.com Canada
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
NVAX: Strategic shift to licensing and Matrix-M partnerships drives growth in vaccines and oncology - TradingView
NVAX: Major pharma partnerships, Matrix-M expansion, and global commercialization drive future growth - TradingView
GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
NVAX Form 4 FilingsNovavax Inc SEC Form 4 - Stock Titan
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Trading the Move, Not the Narrative: (NVAX) Edition - Stock Traders Daily
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax Inc. (NVAX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Novavax Inc (NVAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Novavax to Participate in September Investor Conferences - Morningstar
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax Stock Rises Despite No Confirmed News Behind the Matrix-M Rumor - Benzinga
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story? - Yahoo Finance
What's Going On With Novavax Stock? - Benzinga
Novavax's Nuvaxovid Gets XFG-Variant Approval in US, EU, and Japan Ahead of 2026-2027 Season - BioPharm International
Novavax Stock Climbs Monday: What's Going On? - Benzinga
How Expanded Nuvaxovid Royalties and Partner-led Execution Could Shape Novavax’s (NVAX) Investment Narrative - Yahoo Finance
NVAX Stock Climbs As Partnership Model Keeps COVID Vaccine Cash Flow Open - TradingView
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update - marketscreener.com
Gaithersburg's Novavax Sees Its Licensing Strategy Pay Off With XFG Vaccine Approvals Across Three Major Markets - biobuzz.io
Novavax partners receive approvals for updated COVID-19 vaccine By Investing.com - Investing.com Canada
Novavax's protein-based COVID vaccine gets approvals in the U.S., EU and Japan - Stock Titan
Novavax wins approvals for updated COVID shot (NVAX:NASDAQ) - Seeking Alpha
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax - Benzinga
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax Stock Rallies Tuesday: What's Happening? - TradingView
Novavax Inc. Stock Rallies 6.5%, Outperforms Peers - webull.com
Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical - Yahoo Finance
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough - Barchart.com
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):